How'd you fix Precision Medicine Group's revenue issues in 2026?
Direct Answer Precision Medicine Group is stuck in a commodity CRO trap—competing on price against IQVIA, ICON, and Parexel while watching oncology budgets tighten post-Blackstone/H&F ownership. The 2026 fix: anchor revenue to real-world-ev…
Read full answer ↗